Braskem S.A. (NYSE:BAK - Get Free Report) fell 6.3% on Friday . The company traded as low as $3.83 and last traded at $3.80. 696,705 shares were traded during mid-day trading, a decline of 15% from the average session volume of 816,002 shares. The stock had previously closed at $4.05.
Analyst Upgrades and Downgrades
Separately, Scotiabank lowered Braskem from a "sector outperform" rating to a "sector perform" rating in a research note on Monday, March 3rd.
Check Out Our Latest Stock Analysis on BAK
Braskem Stock Down 6.4%
The stock has a market cap of $1.51 billion, a P/E ratio of -1.07 and a beta of 1.83. The business has a 50 day moving average price of $3.66 and a two-hundred day moving average price of $4.10.
Braskem (NYSE:BAK - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.30 EPS for the quarter, topping analysts' consensus estimates of $0.03 by $0.27. The company had revenue of $3.60 billion for the quarter, compared to the consensus estimate of $22.86 billion. Braskem had a negative return on equity of 439.59% and a negative net margin of 9.88%. On average, research analysts forecast that Braskem S.A. will post -0.77 earnings per share for the current year.
Institutional Investors Weigh In On Braskem
Hedge funds have recently made changes to their positions in the company. JPMorgan Chase & Co. lifted its position in shares of Braskem by 876.1% in the third quarter. JPMorgan Chase & Co. now owns 5,427 shares of the company's stock worth $40,000 after buying an additional 4,871 shares in the last quarter. R Squared Ltd purchased a new stake in Braskem during the fourth quarter valued at approximately $44,000. Blue Trust Inc. raised its position in Braskem by 2,510.3% during the fourth quarter. Blue Trust Inc. now owns 13,130 shares of the company's stock valued at $51,000 after purchasing an additional 12,627 shares during the period. Signaturefd LLC purchased a new stake in Braskem during the fourth quarter valued at approximately $53,000. Finally, Ballentine Partners LLC purchased a new stake in Braskem during the first quarter valued at approximately $58,000.
Braskem Company Profile
(
Get Free Report)
Braskem SA, together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.
Featured Articles
Before you consider Braskem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Braskem wasn't on the list.
While Braskem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.